| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | Aquaporin_12 | 4.44e-05 | 2 | 125 | 2 | IPR023265 | |
| Domain | DUF4599 | 6.16e-05 | 12 | 125 | 3 | PF15371 | |
| Domain | DUF4599 | 6.16e-05 | 12 | 125 | 3 | IPR027970 | |
| Domain | Laminin_EGF | 8.53e-05 | 35 | 125 | 4 | PF00053 | |
| Domain | Laminin_EGF | 1.18e-04 | 38 | 125 | 4 | IPR002049 | |
| Domain | Aquaporin_11/12 | 1.33e-04 | 3 | 125 | 2 | IPR016697 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 CEP192 TNRC6C SCAF1 CELSR2 ADAMTS7 SETD5 MTHFR SPHK1 GLI1 SBF2 ENTPD2 PKD1 NAV2 BAMBI PCNX1 ULK1 LTK HERC1 MCF2L MBD5 DOCK6 | 1.76e-10 | 1105 | 131 | 22 | 35748872 |
| Pubmed | CASP8AP2 UBAP2 TRIM35 FRMD4B MAST4 HECW2 TET1 NAV2 UNK PCNX1 CACNA1G LZTS2 DOCK6 HERC4 LCOR | 1.68e-09 | 529 | 131 | 15 | 14621295 | |
| Pubmed | 2.87e-09 | 6 | 131 | 4 | 20850414 | ||
| Pubmed | Targeted disruption of the spermatid-specific gene Spata31 causes male infertility. | 2.87e-09 | 6 | 131 | 4 | 25930072 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UBAP2 GIT1 BAG3 PSD3 WWTR1 CEP192 SPICE1 MAST4 KCNQ5 NFATC3 PI4KB TET1 PRKAA2 NAV2 PLEKHA2 TAB1 DOCK6 | 2.83e-08 | 861 | 131 | 17 | 36931259 |
| Pubmed | 5.65e-07 | 18 | 131 | 4 | 17522155 | ||
| Pubmed | 1.93e-06 | 24 | 131 | 4 | 32212159 | ||
| Pubmed | NUSAP1 KRT14 EYA4 KRT16 BAG3 PSD3 NCBP1 CEP192 SPICE1 CNNM1 SBF2 TAB1 LZTS2 HERC1 PRRC2A SNTB2 | 2.26e-06 | 1049 | 131 | 16 | 27880917 | |
| Pubmed | 2.87e-06 | 162 | 131 | 7 | 15174051 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CEP192 FOXN3 TNRC6C SSPOP BRWD3 ARHGAP6 KCNQ5 SETD5 ZFP64 SBF2 PRKAA2 ARID5B PLEKHA2 LZTS2 MCF2L MBD5 DOCK6 LCOR GLIS1 | 3.28e-06 | 1489 | 131 | 19 | 28611215 |
| Pubmed | 6.15e-06 | 10 | 131 | 3 | 25601450 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 10. | 6.86e-06 | 345 | 131 | 9 | 15164054 | |
| Pubmed | Onset of taste bud cell renewal starts at birth and coincides with a shift in SHH function. | 8.43e-06 | 11 | 131 | 3 | 34009125 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 10477769 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 36167651 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 28916822 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 26797128 | ||
| Pubmed | cDNA cloning, expression, and assembly characteristics of mouse keratin 16. | 1.41e-05 | 2 | 131 | 2 | 9822705 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 37884491 | ||
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 23541637 | ||
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 1.41e-05 | 2 | 131 | 2 | 15809071 | |
| Pubmed | Profibrotic epithelial phenotype: a central role for MRTF and TAZ. | 1.41e-05 | 2 | 131 | 2 | 30867502 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 31399556 | ||
| Pubmed | TAZ/Wnt-β-catenin/c-MYC axis regulates cystogenesis in polycystic kidney disease. | 1.41e-05 | 2 | 131 | 2 | 33122431 | |
| Pubmed | 1.41e-05 | 2 | 131 | 2 | 19726746 | ||
| Pubmed | Polycystin-1 interacts with TAZ to stimulate osteoblastogenesis and inhibit adipogenesis. | 1.41e-05 | 2 | 131 | 2 | 29202470 | |
| Pubmed | 1.45e-05 | 13 | 131 | 3 | 26989192 | ||
| Pubmed | FLCN, a novel autophagy component, interacts with GABARAP and is regulated by ULK1 phosphorylation. | 1.84e-05 | 14 | 131 | 3 | 25126726 | |
| Pubmed | 2.30e-05 | 15 | 131 | 3 | 31269445 | ||
| Pubmed | 2.44e-05 | 225 | 131 | 7 | 12168954 | ||
| Pubmed | 2.54e-05 | 407 | 131 | 9 | 12693553 | ||
| Pubmed | 3.42e-05 | 17 | 131 | 3 | 37315133 | ||
| Pubmed | 3.42e-05 | 17 | 131 | 3 | 25299669 | ||
| Pubmed | 4.09e-05 | 18 | 131 | 3 | 26209645 | ||
| Pubmed | The role of GLI-SOX2 signaling axis for gemcitabine resistance in pancreatic cancer. | 4.21e-05 | 3 | 131 | 2 | 30382189 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 18005116 | ||
| Pubmed | Yap/Taz Deletion in Gli+ Cell-Derived Myofibroblasts Attenuates Fibrosis. | 4.21e-05 | 3 | 131 | 2 | 28768710 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 33849377 | ||
| Pubmed | Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1). | 4.21e-05 | 3 | 131 | 2 | 18263616 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 23613102 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 27687210 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 38135696 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 29400712 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 20520587 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12079279 | ||
| Pubmed | Sensory deficits in mice hypomorphic for a mammalian homologue of unc-53. | 4.21e-05 | 3 | 131 | 2 | 15158073 | |
| Pubmed | A group of type I keratin genes on human chromosome 17: characterization and expression. | 4.21e-05 | 3 | 131 | 2 | 2451124 | |
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12062803 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 12445204 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 28351953 | ||
| Pubmed | 4.21e-05 | 3 | 131 | 2 | 8636216 | ||
| Pubmed | 4.36e-05 | 102 | 131 | 5 | 10231032 | ||
| Pubmed | 4.36e-05 | 102 | 131 | 5 | 11214970 | ||
| Pubmed | 5.68e-05 | 257 | 131 | 7 | 30945288 | ||
| Pubmed | Identification of proliferative progenitors associated with prominent postnatal growth of the pons. | 8.41e-05 | 4 | 131 | 2 | 27188978 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 33203881 | ||
| Pubmed | Nervous System Regionalization Entails Axial Allocation before Neural Differentiation. | 8.41e-05 | 4 | 131 | 2 | 30343898 | |
| Pubmed | AMPK-dependent phosphorylation of ULK1 regulates ATG9 localization. | 8.41e-05 | 4 | 131 | 2 | 22932492 | |
| Pubmed | 8.41e-05 | 4 | 131 | 2 | 31638828 | ||
| Pubmed | Runx2+ Niche Cells Maintain Incisor Mesenchymal Tissue Homeostasis through IGF Signaling. | 8.41e-05 | 4 | 131 | 2 | 32783935 | |
| Pubmed | SOX2 NUSAP1 HSPG2 EYA4 UBAP2 SH3KBP1 CEP192 TNRC6C NFATC3 PRDX3 ARID5B UNK TAF2 HERC1 PRRC2A SNTB2 | 9.83e-05 | 1429 | 131 | 16 | 35140242 | |
| Pubmed | AMPK Interactome Reveals New Function in Non-homologous End Joining DNA Repair. | 9.84e-05 | 121 | 131 | 5 | 31900314 | |
| Pubmed | Kruppel-like factor 5 is required for formation and differentiation of the bladder urothelium. | 9.98e-05 | 24 | 131 | 3 | 21803035 | |
| Pubmed | 9.98e-05 | 24 | 131 | 3 | 39047740 | ||
| Pubmed | 1.02e-04 | 604 | 131 | 10 | 38803224 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | LAMB4 FAT4 MXRA5 NCBP1 SSPOP OMG SCAF1 HECW2 PKD1 ARID5B PRICKLE2 | 1.13e-04 | 736 | 131 | 11 | 29676528 |
| Pubmed | 1.15e-04 | 125 | 131 | 5 | 29467281 | ||
| Pubmed | System-Wide Modulation of HECT E3 Ligases with Selective Ubiquitin Variant Probes. | 1.27e-04 | 26 | 131 | 3 | 26949039 | |
| Pubmed | Cdx1 autoregulation is governed by a novel Cdx1-LEF1 transcription complex. | 1.40e-04 | 5 | 131 | 2 | 15143193 | |
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 9873228 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 30862798 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 2458356 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 36794754 | ||
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 21072212 | ||
| Pubmed | Sox2-positive dermal papilla cells specify hair follicle type in mammalian epidermis. | 1.40e-04 | 5 | 131 | 2 | 19605494 | |
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 31663850 | ||
| Pubmed | T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. | 1.40e-04 | 5 | 131 | 2 | 19808259 | |
| Pubmed | 1.40e-04 | 5 | 131 | 2 | 15676274 | ||
| Pubmed | 1.43e-04 | 298 | 131 | 7 | 30737378 | ||
| Pubmed | 1.43e-04 | 27 | 131 | 3 | 19168680 | ||
| Pubmed | Genomic architecture of Shh-dependent cochlear morphogenesis. | 1.60e-04 | 28 | 131 | 3 | 31488567 | |
| Pubmed | 1.85e-04 | 415 | 131 | 8 | 16385451 | ||
| Pubmed | 1.90e-04 | 75 | 131 | 4 | 20637190 | ||
| Pubmed | 1.95e-04 | 140 | 131 | 5 | 26930384 | ||
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 27721022 | ||
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 33895473 | ||
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 38816354 | ||
| Pubmed | SOX2 regulates acinar cell development in the salivary gland. | 2.09e-04 | 6 | 131 | 2 | 28623666 | |
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 24903384 | ||
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 30472156 | ||
| Pubmed | Keratin 17 modulates hair follicle cycling in a TNFalpha-dependent fashion. | 2.09e-04 | 6 | 131 | 2 | 16702408 | |
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 30063206 | ||
| Pubmed | 2.09e-04 | 6 | 131 | 2 | 38703771 | ||
| Pubmed | Ciliopathy Protein Tmem107 Plays Multiple Roles in Craniofacial Development. | 2.09e-04 | 6 | 131 | 2 | 28954202 | |
| Pubmed | A novel gene, GliH1, with homology to the Gli zinc finger domain not required for mouse development. | 2.09e-04 | 6 | 131 | 2 | 12385751 | |
| Pubmed | A RhoA-YAP-c-Myc signaling axis promotes the development of polycystic kidney disease. | 2.09e-04 | 6 | 131 | 2 | 29891559 | |
| Pubmed | 2.17e-04 | 31 | 131 | 3 | 30153454 | ||
| Pubmed | STK40 Is a Pseudokinase that Binds the E3 Ubiquitin Ligase COP1. | 2.17e-04 | 31 | 131 | 3 | 28089446 | |
| Pubmed | SOX2 NUSAP1 POC1A CEP192 SETD5 GLI1 SBF2 TET1 ARID5B N4BP2L2 HERC1 HERC4 MRTFA | 2.38e-04 | 1084 | 131 | 13 | 11544199 | |
| Pubmed | 2.62e-04 | 33 | 131 | 3 | 27414999 | ||
| Interaction | TOP3B interactions | HSPG2 UBAP2 POC1A CEP192 TNRC6C SCAF1 CELSR2 ADAMTS7 SETD5 MTHFR SPHK1 GLI1 SBF2 ENTPD2 PKD1 NAV2 UNK BAMBI PCNX1 ULK1 LTK HERC1 MCF2L MBD5 DOCK6 PRRC2A | 1.79e-06 | 1470 | 129 | 26 | int:TOP3B |
| Interaction | CEP85 interactions | 1.33e-05 | 169 | 129 | 8 | int:CEP85 | |
| Interaction | TCHP interactions | 2.16e-05 | 131 | 129 | 7 | int:TCHP | |
| Interaction | TNRC6C interactions | 3.02e-05 | 138 | 129 | 7 | int:TNRC6C | |
| Interaction | VPS37B interactions | 3.19e-05 | 57 | 129 | 5 | int:VPS37B | |
| Interaction | AMOT interactions | KRT14 EYA4 KRT16 BAG3 WWTR1 CEP192 SPICE1 HECW2 PRKAA2 LZTS2 | 3.32e-05 | 312 | 129 | 10 | int:AMOT |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 2.27e-04 | 8 | 132 | 2 | chr9q12 | |
| GeneFamily | Keratins, type I | 2.52e-04 | 28 | 80 | 3 | 608 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KRT14 SH3KBP1 CPEB3 FOXN3 TNRC6C SSPOP FRMD4B RNF157 RYR2 MAST4 ASXL3 SBF2 PRKAA2 PRICKLE2 TENM1 NAV3 CACNA1G HERC1 MCF2L CCDC144A | 6.23e-07 | 1106 | 131 | 20 | M39071 |
| Coexpression | BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP | 1.69e-05 | 31 | 131 | 4 | M816 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | FAT4 EYA4 CRLF1 GPATCH1 PSD3 GRB14 WWTR1 TNRC6C FRMD4B RNF157 ADAMTS7 SETD5 GLI1 HECW2 ASXL3 PI4KB TET1 PKD1 ARID5B PRICKLE2 NAV3 CACNA1G PRRC2A | 5.37e-07 | 1208 | 125 | 23 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | SOX2 MTF2 ANKRD10 FRMD4B BRWD3 RNF157 RYR2 MAST4 ASXL3 TET1 ARID5B NAV2 HERC1 PHOX2B LCOR SNTB2 | 2.03e-05 | 804 | 125 | 16 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#1_top-relative-expression-ranked_500 | 4.70e-05 | 67 | 125 | 5 | gudmap_developingGonad_e12.5_ovary_k1_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_1000 | FAT4 EML4 TRIM35 IRAG1 BRWD3 RNF157 RYR2 ARHGAP6 KCNQ5 SETD5 ARID5B BAMBI TAF2 LCOR SNTB2 | 8.59e-05 | 811 | 125 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_1000 | SOX2 FAT4 EML4 IRAG1 BRWD3 RNF157 RYR2 ARHGAP6 KCNQ5 SETD5 HECW2 TENM1 BAMBI PHOX2B SNTB2 | 1.05e-04 | 826 | 125 | 15 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | SOX2 KRT14 EYA4 CRLF1 MTF2 WDR31 PSD3 NCBP1 BRWD3 ARHGAP6 HECW2 TENM1 TAF2 PHOX2B LCOR | 1.20e-04 | 836 | 125 | 15 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 1.38e-04 | 403 | 125 | 10 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_500 | 1.54e-04 | 46 | 125 | 4 | gudmap_developingGonad_e12.5_epididymis_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_200 | 1.80e-04 | 19 | 125 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | SOX2 SAP25 KRT14 CRLF1 WDR31 PSD3 WWTR1 ARHGAP6 CELSR2 ADAMTS7 HECW2 ARID5B NAV3 CACNA1G PRR14L GLIS1 | 1.92e-04 | 973 | 125 | 16 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | FAT4 IRAG1 BRWD3 RNF157 RYR2 ARHGAP6 KCNQ5 SETD5 PHOX2B SNTB2 | 2.01e-04 | 422 | 125 | 10 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.25e-07 | 195 | 132 | 8 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-07 | 200 | 132 | 8 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.52e-07 | 200 | 132 | 8 | 27507c4b41d45c7cc50e4993169c0302be22ee34 | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX-Endothelial-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.52e-07 | 200 | 132 | 8 | b65fb8d378abd91cdabf5faac5f4b90d527f8c44 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial-Endothelial-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-07 | 200 | 132 | 8 | 2cb6e35add34b9dc564ebcf5d3cbc761325ca9f4 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 177 | 132 | 7 | e65c0568dc5852108e9802273499bc7cf88fafab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-06 | 177 | 132 | 7 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.13e-06 | 180 | 132 | 7 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-06 | 184 | 132 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.31e-06 | 184 | 132 | 7 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 1.36e-06 | 185 | 132 | 7 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.41e-06 | 186 | 132 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.62e-06 | 190 | 132 | 7 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-06 | 193 | 132 | 7 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-06 | 193 | 132 | 7 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.80e-06 | 193 | 132 | 7 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-06 | 194 | 132 | 7 | 68004855b23fe1e31e8452d70effabc78a4a0bd3 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-06 | 197 | 132 | 7 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-06 | 197 | 132 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | distal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.13e-06 | 198 | 132 | 7 | 00fdee373eaa43c9ce897f2ba2ecbe94cedea93a | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-KRT5-/KRT17+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.20e-06 | 199 | 132 | 7 | 3b1f56c8b40bb36922a31d2d440a8c468a8aa3f1 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.20e-06 | 199 | 132 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-06 | 200 | 132 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.28e-06 | 200 | 132 | 7 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.22e-05 | 171 | 132 | 6 | b3e6e31dfe3623b960ccf692fdbd236fa4039923 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 172 | 132 | 6 | c6bc78fd63c9479a84ec0552b55c89750cad0fa5 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-05 | 172 | 132 | 6 | bfb87a281a9cf6ad45b310bf8104fc0ab382b549 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.30e-05 | 173 | 132 | 6 | f8e3dded726bb3a6c24bfedf8c6732bb46262308 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.39e-05 | 175 | 132 | 6 | f24b664b9056b5976bf2222e8013f15c09e049ad | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 176 | 132 | 6 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 176 | 132 | 6 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-05 | 179 | 132 | 6 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.73e-05 | 182 | 132 | 6 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | (09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint | 1.93e-05 | 110 | 132 | 5 | fce7d5a0617fc664b657f5bb9abb290e7cc234cb | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.02e-05 | 187 | 132 | 6 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.02e-05 | 187 | 132 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.02e-05 | 187 | 132 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 188 | 132 | 6 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 2.08e-05 | 188 | 132 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.08e-05 | 188 | 132 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.14e-05 | 189 | 132 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.14e-05 | 189 | 132 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.14e-05 | 189 | 132 | 6 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.21e-05 | 190 | 132 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 2.21e-05 | 190 | 132 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 2.27e-05 | 191 | 132 | 6 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.27e-05 | 191 | 132 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-05 | 192 | 132 | 6 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.41e-05 | 193 | 132 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.41e-05 | 193 | 132 | 6 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)|Adult / Lineage, Cell type, age group and donor | 2.41e-05 | 193 | 132 | 6 | 39c6c96a2a100b1b290a779d36cc6bc17245720b | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.41e-05 | 193 | 132 | 6 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.41e-05 | 193 | 132 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.41e-05 | 193 | 132 | 6 | ad3f4fcc8e2816d696cbcde744dc16500e51ccac | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 194 | 132 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-proliferating_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.48e-05 | 194 | 132 | 6 | 8a4be91414a2e69dd410aa75791f16008204c9a1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 194 | 132 | 6 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 194 | 132 | 6 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-05 | 194 | 132 | 6 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.55e-05 | 195 | 132 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.63e-05 | 196 | 132 | 6 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.63e-05 | 196 | 132 | 6 | 686533fd3fba8e4df96b9dd1307e870e89db4332 | |
| ToppCell | COVID-19-lung-Capillary_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.63e-05 | 196 | 132 | 6 | ac28e9be288af6f00a841aea4ce4b99aed6b4505 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 197 | 132 | 6 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.70e-05 | 197 | 132 | 6 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | 18-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 2.78e-05 | 198 | 132 | 6 | 70d3ea0837dd6ad62abdf349e566a2e62c8e345a | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-05 | 198 | 132 | 6 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | wk_15-18-Endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.78e-05 | 198 | 132 | 6 | dcf453e22dba90c0ae349fa6c3d4c20758bb95af | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.78e-05 | 198 | 132 | 6 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 18-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 2.78e-05 | 198 | 132 | 6 | 6b7f1b352dc3a803af87106ffb63944bd4286dfe | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Mucinous-1|TCGA-Stomach / Sample_Type by Project: Shred V9 | 2.81e-05 | 119 | 132 | 5 | 5d5fcddb5723e7a94bfcf56e165a980fa450b789 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-05 | 199 | 132 | 6 | bff61a784ef8bc040f5c7baabccaf7a7cddd5a31 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-05 | 199 | 132 | 6 | f0bf75bfae7b288ecb6801be458b03ebd0108ea7 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.86e-05 | 199 | 132 | 6 | 3cb1d9d9de64ed0a56c4f8d5e2fa02a13a73d8ac | |
| ToppCell | wk_20-22-Endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.86e-05 | 199 | 132 | 6 | 07be9509a8ec9c9a7d721912d77c20e841f49808 | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | 2989325b0e78ab42f362cfb59e34a4fce7f8e869 | |
| ToppCell | Parenchymal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | 0e648e9eb96c83a94505d07323785a7a40997eb0 | |
| ToppCell | 10x5'v1-week_14-16-Endothelial-stroma-tip_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.94e-05 | 200 | 132 | 6 | 77ac1aa73c16a4f595ff01c6b4e171e0b8fed1e6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 200 | 132 | 6 | 9e44da8aaac239ed69d674dcd53800c5eaf397cb | |
| ToppCell | Parenchyma_COVID-19-Endothelial-TX|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 2.94e-05 | 200 | 132 | 6 | abcbd5a156aa4fd51d284441388975c81c0b88ae | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 200 | 132 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.94e-05 | 200 | 132 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-05 | 200 | 132 | 6 | d9d0ffa18e5b4647966e19ad9830cbba6120677e | |
| ToppCell | Lung_Parenchyma-Severe-Endothelial-Endothelial|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.94e-05 | 200 | 132 | 6 | e9d5ba140cabae11c437012d519b85f5412dcc94 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 2.94e-05 | 200 | 132 | 6 | 16a3685c41194a0a4a772e4eee372160263480e0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.94e-05 | 200 | 132 | 6 | 90061284a80d29a4ca6078f578e13d32b8cc80e1 | |
| ToppCell | 356C-Lymphocytic-ILC-ILC-3|ILC / Donor, Lineage, Cell class and subclass (all cells) | 3.24e-05 | 61 | 132 | 4 | d0b33a48ee2faf68b270f9279c630437f3e8b20b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c02-AQP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.46e-05 | 146 | 132 | 5 | 159dd157a74f3c27dc1a1dcbbf0ed8f9462cac9e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.31e-05 | 153 | 132 | 5 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-05 | 155 | 132 | 5 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-04 | 159 | 132 | 5 | ae53ab7a1339007d0b245c6c291ac61e5ff5b682 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 160 | 132 | 5 | 636127753e3a22831f39d4c8170df40901e4329d | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 160 | 132 | 5 | cb8d0dc1a6c69c7a85c5fdd8f0f6cca1b73dfc63 | |
| ToppCell | COVID-19-kidney-Plasma|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.15e-04 | 160 | 132 | 5 | f8d9e459976e711e9ad39ea2b6173140c0589d6e | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.25e-04 | 163 | 132 | 5 | 977a970b1296234c22178420294cea73506ee02f | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.25e-04 | 163 | 132 | 5 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 1.25e-04 | 163 | 132 | 5 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.29e-04 | 164 | 132 | 5 | 3d8ff70fe5582d1fb56b338be8b76fa1428b3657 | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.74e-06 | 198 | 127 | 9 | 5242_DN | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.41e-05 | 195 | 127 | 8 | 5884_UP | |
| Drug | Ioxaglic acid [59017-64-0]; Up 200; 3.2uM; MCF7; HT_HG-U133A | 1.46e-05 | 196 | 127 | 8 | 7470_UP | |
| Drug | Piretanide [55837-27-9]; Up 200; 11uM; MCF7; HT_HG-U133A | 1.52e-05 | 197 | 127 | 8 | 3567_UP | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.57e-05 | 198 | 127 | 8 | 3687_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A | 1.57e-05 | 198 | 127 | 8 | 4592_DN | |
| Drug | 3-nitropropionic acid; Down 200; 10uM; PC3; HT_HG-U133A | 1.69e-05 | 200 | 127 | 8 | 6407_DN | |
| Disease | response to prednisolone | 1.05e-04 | 4 | 124 | 2 | EFO_0009168 | |
| Disease | lymphocyte measurement | 1.39e-04 | 117 | 124 | 5 | EFO_0803546 | |
| Disease | carbonic anhydrase-related protein 10 measurement | 4.82e-04 | 8 | 124 | 2 | EFO_0020233 | |
| Disease | serum gamma-glutamyl transferase measurement | MTF2 EML4 GPATCH1 PSD3 OMG RYR2 CELSR2 PKD1 NAV2 ULK1 LZTS2 PRRC2A | 4.83e-04 | 914 | 124 | 12 | EFO_0004532 |
| Disease | Paroxysmal atrial fibrillation | 5.26e-04 | 156 | 124 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 5.26e-04 | 156 | 124 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 5.26e-04 | 156 | 124 | 5 | C2585653 | |
| Disease | Atrial Fibrillation | 5.90e-04 | 160 | 124 | 5 | C0004238 | |
| Disease | waist-hip ratio | FNDC3B EYA4 CPEB3 CEP192 KCNB2 RNF157 MAST4 SBF2 PKD1 ARID5B NAV3 PCNX1 TAB1 DOCK6 | 6.54e-04 | 1226 | 124 | 14 | EFO_0004343 |
| Disease | long QT syndrome (implicated_via_orthology) | 7.71e-04 | 10 | 124 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 7.91e-04 | 43 | 124 | 3 | EFO_0022290 | |
| Disease | cortical thickness | FNIP2 HSPG2 EYA4 ADAMTS8 IRAG1 FRMD4B MAST4 ADAMTS7 SETD5 MTHFR PKD1 NAV3 NAV2 | 8.36e-04 | 1113 | 124 | 13 | EFO_0004840 |
| Disease | atrial fibrillation | 1.00e-03 | 371 | 124 | 7 | EFO_0000275 | |
| Disease | heart failure | 1.13e-03 | 185 | 124 | 5 | EFO_0003144 | |
| Disease | antihyperlipidemic drug use measurement | 1.43e-03 | 115 | 124 | 4 | EFO_0803367 | |
| Disease | coronary artery disease | FNDC3B FAT4 PSD3 IRAG1 KCNB2 MAST4 CELSR2 ADAMTS7 MTHFR N4BP2L2 MCF2L DOCK6 MRTFA | 1.57e-03 | 1194 | 124 | 13 | EFO_0001645 |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.81e-03 | 303 | 124 | 6 | EFO_0004612, EFO_0020945 | |
| Disease | HbA1c measurement | 2.24e-03 | 675 | 124 | 9 | EFO_0004541 | |
| Disease | cup-to-disc ratio measurement | 2.32e-03 | 430 | 124 | 7 | EFO_0006939 | |
| Disease | Bladder Neoplasm | 2.93e-03 | 140 | 124 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 3.01e-03 | 141 | 124 | 4 | C0005684 | |
| Disease | corneal hysteresis | 3.17e-03 | 20 | 124 | 2 | EFO_0010066 | |
| Disease | seborrheic dermatitis | 3.17e-03 | 20 | 124 | 2 | EFO_1000764 | |
| Disease | attention deficit hyperactivity disorder (is_implicated_in) | 3.17e-03 | 20 | 124 | 2 | DOID:1094 (is_implicated_in) | |
| Disease | dilated cardiomyopathy | 3.17e-03 | 20 | 124 | 2 | EFO_0000407 | |
| Disease | stroke, coronary artery disease | 3.49e-03 | 21 | 124 | 2 | EFO_0000712, EFO_0001645 | |
| Disease | Hepatitis | 3.83e-03 | 22 | 124 | 2 | HP_0012115 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VACSGPTHASGTLSR | 126 | Q6ZRM9 | |
| SQTPAGLQSLCTGRH | 36 | P0DMU3 | |
| GLQSLCTGRHPSLSA | 41 | P0DMU3 | |
| GGLCPSNTSLLATSS | 241 | P47902 | |
| AQSCSSALRTSVPHG | 136 | Q8IXF9 | |
| GSLHLNGSPSSCIAS | 346 | Q9NXR5 | |
| GNSCRKVSGSLTPTN | 686 | Q9UP79 | |
| SGSSTPQRSCSAAGL | 481 | P54646 | |
| RNPSICSADHGRSSS | 4801 | Q6V0I7 | |
| VLQHATRGSRSCGPT | 196 | C9J069 | |
| LAPGLGSTRSSALCS | 116 | Q16570 | |
| RPGVQISCSSFSSGG | 316 | Q6RI45 | |
| GSCLSGSQRTLPSAS | 411 | P35368 | |
| SPLLSCSQEGSRHTS | 571 | Q9Y2X7 | |
| GSSQTGLHRIPQCSS | 1191 | Q8IYA2 | |
| GLHRIPQCSSFSSSS | 1196 | Q8IYA2 | |
| LPLEQCTGSSRGSSA | 2856 | Q9HCU4 | |
| AQSCSSALRTSVPHG | 136 | A6NM10 | |
| GRCPSSLSNSRTHKN | 431 | Q9UKL3 | |
| SCGTSGLPVSAQTAL | 386 | Q9C0F0 | |
| RLAQRGDSSAPSTCG | 191 | Q9UKP4 | |
| SNGDPRSSQSLHCLS | 316 | O95741 | |
| PCSIGRTEGTAHSSN | 436 | Q9Y483 | |
| GHTATLRCSATGSPA | 3226 | P98160 | |
| NGHSRPGTATCSERS | 426 | Q9P2P5 | |
| CVNFSPSGHLLASGS | 66 | Q8NBT0 | |
| RGNSSLNPCLEGSAS | 6 | P42898 | |
| GCPSGTLSDSGRNSL | 211 | Q9BRK4 | |
| SRSPRGLSHLGQSLC | 191 | Q96PY0 | |
| SSNSLPGHSVALCLA | 491 | Q09161 | |
| STISSNNGCHPGGLT | 26 | Q6A163 | |
| RSSLTLNCQGSGFAP | 1456 | Q86WG5 | |
| ISSVLAGGSCRAPST | 31 | P02533 | |
| LGSRNFSSCPSGSIQ | 6 | Q6ZP29 | |
| SVLHCSGTRTLQGGP | 46 | Q96FN5 | |
| LSGSAQNSGCLSRST | 666 | Q9NR82 | |
| CLAAAGRAGLSTSPS | 3226 | Q15751 | |
| SARVSLSGSSDPHLC | 296 | Q9Y5L3 | |
| GPLGRSTCSAAQRDS | 876 | Q9Y6F6 | |
| STCGASGRHGPTQTQ | 71 | P29376 | |
| SSRAQLSPAAAAGHC | 471 | Q9BRR8 | |
| SGLACVQHGLPSSSS | 2181 | Q96RV3 | |
| TSLSHSPGCSSTQGN | 96 | Q96JN0 | |
| IPNLGTTGSQHCSSR | 26 | Q8IVL0 | |
| SPTSASACGAQGLRQ | 1221 | Q8IVL0 | |
| SLTSLGPSQGSSCLE | 126 | A6NFA0 | |
| GPSQGSSCLEALSTS | 131 | A6NFA0 | |
| CGRQHTSAFVPSSGR | 301 | Q5GLZ8 | |
| SLGCDLPQTHSLSNR | 21 | P01569 | |
| ISSVLAGGSCRAPST | 31 | P08779 | |
| LVAFINSRCTSPGGS | 106 | P08151 | |
| VQPGGSLRLSCSASG | 31 | A0A0J9YX35 | |
| SPAQLNGGSACSSRS | 261 | Q15599 | |
| SQGRSCGPASQSTLG | 251 | Q9BXS6 | |
| ASTNGSRLLACGPTL | 96 | Q13349 | |
| GSLNCLQTPSSTSRG | 316 | P35227 | |
| SSSLRAGPCSLSQGN | 761 | O43182 | |
| GGLSTQQCRTRHPIS | 511 | Q7Z3G6 | |
| PESSSQHCRQRSGSL | 681 | Q9Y2L6 | |
| SGLSQTQSPLQSGCL | 206 | O95677 | |
| SGSQCGLHSPLQSDN | 681 | Q92953 | |
| GSPHSSRRCSSSLGV | 31 | Q96HP0 | |
| SNSPLTHGCLDSLAS | 61 | Q13145 | |
| LGGQETQPSSSCSRS | 471 | O43497 | |
| GDQALSSGLSSPTRC | 416 | Q8NE35 | |
| SSGLSSPTRCQNGER | 421 | Q8NE35 | |
| STGGHSQCSESLPVR | 651 | Q53EP0 | |
| QNSLGPCRTGSNLAH | 206 | Q9P278 | |
| PESSGISVSSGLSQC | 11 | O00409 | |
| AEGASPSSLGLRTCT | 416 | Q8IYS4 | |
| PSSLGLRTCTGKSQL | 421 | Q8IYS4 | |
| PRGQGSLSILCSAVS | 196 | Q7Z692 | |
| SNGGSILTVSRTPCD | 201 | Q9HBG7 | |
| LSVRLGPSGSAQCLS | 1111 | O15068 | |
| CSGHGSRTPASALVA | 16 | O15021 | |
| CLNRSLSSGESLPGS | 1286 | O15021 | |
| QSSHLSSNSTPGCGA | 711 | Q9P267 | |
| STGSTTLPQCHAGNA | 1271 | Q8TEP8 | |
| CLRLGTHGSPTASSQ | 411 | Q14449 | |
| PGCHGSLTLSTNALQ | 1406 | A4D0S4 | |
| LAPCSRSTSGGTAAL | 11 | P01860 | |
| SCITNGSGANRKPSH | 81 | Q9HC35 | |
| PSAATHSLGLGSNLS | 271 | A6NIJ5 | |
| TSLSAHCRGPLATGL | 6 | Q8NBF1 | |
| GSSQTGLHRIPQCSS | 1381 | A2RUR9 | |
| GLHRIPQCSSFSSSS | 1386 | A2RUR9 | |
| LSCSALGSSPVHRAQ | 141 | O60269 | |
| ASLPSSGRSSLGSHQ | 186 | O95817 | |
| SNQTSCRLAGLKPGT | 291 | O75462 | |
| TTTTARPSSNCGGFL | 1756 | Q9UGM3 | |
| HSCGRDPSGSQQSAS | 326 | Q9H228 | |
| GPCTGNQQSLAHSRL | 3926 | Q92736 | |
| HASSTGNLGLLCRSG | 471 | Q14154 | |
| CALNFGPRGSSTVTI | 2311 | P98161 | |
| LVSSGSNNSLPCGSP | 1016 | Q5THK1 | |
| LNPGHCGSLSRSTGF | 141 | Q6UW15 | |
| CSNSGRLSGPAELRS | 1236 | Q96PC5 | |
| SSGASFSGRTLCHPS | 26 | Q8TEE9 | |
| SSLSSGPNSILCRGR | 321 | Q9HB19 | |
| PTVRGCNGSLSGALS | 16 | Q5JUK2 | |
| TSSSHSRAPCQAGDL | 256 | P48431 | |
| SAPCLLGSRVFSQGS | 341 | Q9UPQ4 | |
| SSQPRLSAAGSSHGL | 1611 | Q9HCJ0 | |
| SSGAIDQSSCTGTPL | 486 | Q96PX1 | |
| TCAALPGGLHSTRQT | 1786 | A2VEC9 | |
| LPLCHLSGVGSASNR | 21 | Q15750 | |
| SPSCLLSSGQEVNGS | 36 | Q0D2K3 | |
| SRSALIPQHSAGCDS | 1081 | Q6P1X5 | |
| LTQLAGPSSATCESG | 836 | Q8IWB4 | |
| GSSSAPERNCVGSSL | 26 | P57086 | |
| GSTGSTPLLRNSHSN | 1876 | Q8IVL1 | |
| QGSGCSRAPSQVSIS | 1961 | Q8IVL1 | |
| SSLGTAGHRANSPSL | 576 | Q96B97 | |
| SGDSQVSSGPCSQRS | 1656 | P48634 | |
| HSGNSTGSNLPRRSC | 1326 | Q9C0A6 | |
| GSNGLTSTQPLSCDS | 1341 | Q9UKZ4 | |
| GRTSLTNLLCSGSSQ | 36 | P30048 | |
| QGSQLPCFHGSSTIR | 756 | Q9UBF8 | |
| CGLARQNSTSLTGKP | 326 | Q969V6 | |
| CSGRNLSTLPSGLQE | 41 | P23515 | |
| SCQPGSGSRDTALIA | 411 | Q14162 | |
| NSCSPLNATSGSGRF | 816 | Q8N0Z3 | |
| LRNCLALGGSTSPTS | 311 | Q8NFU7 | |
| IHRIRGSSPSSCGSS | 506 | O00327 | |
| LGGNPGSTSAATCTR | 381 | Q14865 | |
| GSSVFLNRSPSRCSG | 721 | Q9NRU3 | |
| SPGSQSNARILGVCS | 2436 | A4UGR9 | |
| LTQLAGPSSATCESG | 836 | Q5VYP0 | |
| SCSPQSLSSVLGSGF | 346 | Q5T6F2 | |
| NSLCLGGTPASASSS | 766 | Q5T6F2 | |
| LTQLAGPSSATCESG | 836 | Q5TZJ5 | |
| LTQLAGPSSATCESG | 836 | Q5VU36 | |
| SSRPTCARHLTLGTG | 166 | Q9H7N4 | |
| GCSLRSTGSPASLAS | 191 | Q8IUC6 | |
| SSSLGGCLLPQSQAR | 776 | Q5VZP5 | |
| QPSQGCSRQALGHLS | 11 | Q7L0L9 | |
| CSRQALGHLSGRGPS | 16 | Q7L0L9 | |
| TGQGGLSAPSSLICH | 981 | Q12968 | |
| LRSGSGCQVSGSPLA | 361 | Q3C1V9 | |
| LSGGVSLCASHSQPA | 66 | Q6ZTR6 | |
| RGPCSNGEAASTSSL | 101 | A8MUI8 | |
| CSLPAGSGNALAASL | 106 | Q9NYA1 | |
| GLAVSPDSSQLCTGS | 151 | Q8NA23 | |
| ATRLVHSGSGCRSPS | 381 | Q13425 | |
| CRNSSLGSPSNLCGS | 371 | Q9C0B0 | |
| TPGSCSLGTLRDHQS | 61 | Q99453 | |
| PRHLISSAGLCNSSS | 341 | Q9NYI0 | |
| QSGCQLTGTSAAAPS | 51 | Q9NTW7 | |
| RTSGLGCRLHSAPNL | 546 | O75385 | |
| RSHSSPASLQLGTGA | 86 | Q9GZV5 | |
| CSLHSASPASVRSLG | 321 | Q9P206 | |
| AGHTISLNCSAAGTP | 2556 | Q9NR99 | |
| SENRSSVHPSGNGCS | 341 | Q92802 |